Kadcyla Drug Interactions: 510 Major, 620 Moderate
Kadcyla (Ado-Trastuzumab Emtansine) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Kadcyla. Always confirm against the full prescribing information.
100 interactions
Abacavir
The risk or severity of liver damage can be increased when Abacavir is combined with Trastuzumab emtansine.
Level 2 evidence
Abemaciclib
The serum concentration of Abemaciclib can be increased when it is combined with Trastuzumab emtansine.
Level 2 evidence
Abiraterone
The risk or severity of liver damage can be increased when Trastuzumab emtansine is combined with Abiraterone.
Level 2 evidence
Acamprosate
The risk or severity of liver damage can be increased when Acamprosate is combined with Trastuzumab emtansine.
Level 2 evidence
Acarbose
The risk or severity of liver damage can be increased when Acarbose is combined with Trastuzumab emtansine.
Level 2 evidence
Acebutolol
The risk or severity of liver damage can be increased when Acebutolol is combined with Trastuzumab emtansine.
Level 2 evidence
Aceclofenac
The risk or severity of liver damage can be increased when Trastuzumab emtansine is combined with Aceclofenac.
Level 2 evidence
Acetohydroxamic acid
The risk or severity of liver damage can be increased when Acetohydroxamic acid is combined with Trastuzumab emtansine.
Level 2 evidence
Acetylsalicylic acid
The risk or severity of liver damage can be increased when Acetylsalicylic acid is combined with Trastuzumab emtansine.
Level 2 evidence
Acitretin
The risk or severity of liver damage can be increased when Acitretin is combined with Trastuzumab emtansine.
Level 2 evidence
Acyclovir
The risk or severity of liver damage can be increased when Acyclovir is combined with Trastuzumab emtansine.
Level 2 evidence
Adefovir dipivoxil
The risk or severity of liver damage can be increased when Adefovir dipivoxil is combined with Trastuzumab emtansine.
Level 2 evidence
Enter your NPI to unlock 36 major interactions for Kadcyla
Kadcyla (Ado-Trastuzumab Emtansine) has 1279 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Kadcyla (Ado-Trastuzumab Emtansine) has 510 major, 620 moderate, and 149 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Kadcyla. Always confirm against the full prescribing information.